Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
William Enright is Director at Bullfrog AI Holdings. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 15, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Jun 11, 202615Kdisclosed Jun 15
DetailsOfficial recordWilliam Enright bought shares on the open market in 2018 and 2023, and has not bought since 2023 across 2 companies.
William Enright reported 2 open-market purchases and 0 sales since 2018; purchases in 2 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $20K1×1 trade | — |
| 2018 | $6631×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
William Enright bought shares on the open market in 2018 and 2023, and has not bought since 2023 across 2 companies.
In SEC filings since 2018: the latest open-market purchase is from 2023; no open-market sale is on record.
2 companies: Bullfrog AI Holdings (BFRG, 2023), Altimmune (ALT, 2018).
William Enright reported 1 open-market purchase and 0 sales here, 2023.
William Enright reported 1 open-market purchase and 0 sales here, 2018.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
